The worldwide market for Wound Debridement Products is projected to increase ~22% from 2017 to 2022E, according to SmartTRAK estimates. SmartTRAK expects this robust growth to continue, driven by an increasing prevalence of chronic wounds, a growing awareness of the importance of dealing with biofilm, as well as a strong pipeline of innovative technologies and products.

The definition of wound debridement is today well established. It is the mechanical removal of dead, damaged or infected tissue to improve the healing potential of the remaining tissue. Effective and gentle wound debridement is critical for a successful healing process.

The actual debridement, however, can be performed in multiple ways....

SmartTRAK will be hosting an Executive Briefing and Reception titled "Advanced Wound Care: Trends, Opportunities & Innovation"  at the 2018 SAWC Spring - The Symposium on Advanced Wound Care - on Wednesday, April 25th at 5pm in the Westin Charlotte Hotel, Uptown Room.

Moderated by Don Urbanowicz, Principal, Urbanowicz Consulting, the panel will include Susan Paquette, VP & GM Wound, BioMedGPS and Lennart Stadler, SmartTRAK's Senior Analyst, Wound Care. The discussion will focus on the latest trends and technologies impacting the Global Advanced Wound Care Market.
            

The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.

As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by Baxter, Ethicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...

EWMA 2017, held in Amsterdam,  provided a unique and interesting look at the European Advanced Wound Care market - showcasing products approved for the European market but not yet launched in the US. Europe has always been a breeding ground for innovative medical devices, and has long served as a gateway for companies looking to bring new devices to the US. While some of these companies have no desire to enter the US market, many look to the US market with high expectations. It is the largest medical device market in the world, with one language and one regulatory and reimbursement system, and is much less complicated than the European market where distribution partnerships and regulatory approvals are sometimes needed for each country.

Q317 Infection Prevention: Vascular Access Adjunct Products 

A slowdown in growth for another quarter.

By Susan Paquette, VP Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market reached new market revenue heights in dollars and growth.

Q317 US Surgical Matrices Market: Strong Growth Continues in Breast Matrices 

The US Surgical Matrices Market saw growth in Q317 as sales of allografts fueled double-digit growth in breast matrices and biosynthetics offset declines in biologics in hernia repair.

By Doug Devens, Senior Analyst Biosurgery

The US Surgical Matrices market, consisting of hernia repair and breast reconstruction products, continued uneven growth in Q317.  Allergan continued to capture share in the overall market, using its growth in allografts to increase its share.

Q317 Market Recap Advanced Wound Care 

Biologics and single-use NPWT devices’ strong growth helps boost sluggish advanced dressing performance.

By Susan Paquette, VP Wound and
Lennart Stadler, Senior Analyst Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew in spite of a weak performance with market leaders.

Q317 Market Recap Biosurgery Hemostats & Sealants: Supply Chain Disruptions 

By Doug Devens, Senior Analyst Biosurgery

Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.

SmartTRAK is excited to attend Desert Foot 2017 on Nov-29 through Dec-2, 2017  at the Grand Sheraton, Phoenix AZ. Desert Foot is the Annual Multi-Disciplinary Diabetic Limb Salvage Conference which honors our Federal Services Healthcare Professionals.

SmartTRAK is excited to be attending the ACS Clinical Congress 2017 on Oct 22-26, 2017 at the San Diego Convention Center in San Diego, California.

The hallmarks of the Clinical Congress are a broad range of outstanding hands-on and didactic learning opportunities and timely discourse on the most relevant surgical practices and research, along with unparalleled access to peers.

Please look for SmartTRAK's Susan Paquette, MS, MBA, Vice President and General Manager, Wound; Doug Devens, Senior Analyst, Biosurgery; Geoffrey Brown, Director Corporate Accounts, Wound Care. Contact Us for a meeting!